1. Home
  2. CCB vs AMLX Comparison

CCB vs AMLX Comparison

Compare CCB & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coastal Financial Corporation

CCB

Coastal Financial Corporation

HOLD

Current Price

$74.19

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$13.62

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCB
AMLX
Founded
1997
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
CCB
AMLX
Price
$74.19
$13.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
9
Target Price
$126.67
$20.11
AVG Volume (30 Days)
133.3K
843.7K
Earning Date
04-28-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.46
EPS
3.06
N/A
Revenue
N/A
$380,786,000.00
Revenue This Year
$96.61
N/A
Revenue Next Year
$22.66
N/A
P/E Ratio
$24.43
N/A
Revenue Growth
N/A
1612.94
52 Week Low
$70.72
$3.11
52 Week High
$120.05
$17.49

Technical Indicators

Market Signals
Indicator
CCB
AMLX
Relative Strength Index (RSI) 35.92 45.73
Support Level $70.72 $13.36
Resistance Level $118.72 $15.37
Average True Range (ATR) 2.60 0.68
MACD 0.52 -0.08
Stochastic Oscillator 5.08 22.82

Price Performance

Historical Comparison
CCB
AMLX

About CCB Coastal Financial Corporation

Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company. The maximum revenue of the company is generated from the CCBX segment.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

Share on Social Networks: